IL131502A0 - Use of 9,10-secocholesta-5,7,10 (19)-triene-1,3-diol or alfacacidol - Google Patents
Use of 9,10-secocholesta-5,7,10 (19)-triene-1,3-diol or alfacacidolInfo
- Publication number
- IL131502A0 IL131502A0 IL13150298A IL13150298A IL131502A0 IL 131502 A0 IL131502 A0 IL 131502A0 IL 13150298 A IL13150298 A IL 13150298A IL 13150298 A IL13150298 A IL 13150298A IL 131502 A0 IL131502 A0 IL 131502A0
- Authority
- IL
- Israel
- Prior art keywords
- alfacacidol
- secocholesta
- triene
- diol
- cancer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Manufacture Of Tobacco Products (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
The invention concerns the use of 9,10-secocholesta-5,7,10(19)-triene-1,3-diol, or alfacacidol, for preparing a medicine for the treatment and/or prevention of solid cancer in human beings, in particular lung cancer and brain cancer. The effective dose ranges between 0.25 and 10 mu g/day for an adult weighing 60 Kg.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9702247A FR2759586B1 (en) | 1997-02-20 | 1997-02-20 | ANTI-CANCER TYPE DRUG COMPRISING AT LEAST AS THE ACTIVE INGREDIENT OF 1-ALPHA HYDROXYCALCIFEROL OR ALFACALCIDOL |
PCT/FR1998/000347 WO1998036754A1 (en) | 1997-02-20 | 1998-02-20 | Use of 9,10-secocholesta-5,7,10(19)-triene-1,3-diol, or alfacacidol |
Publications (1)
Publication Number | Publication Date |
---|---|
IL131502A0 true IL131502A0 (en) | 2001-01-28 |
Family
ID=9504159
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13150298A IL131502A0 (en) | 1997-02-20 | 1998-02-20 | Use of 9,10-secocholesta-5,7,10 (19)-triene-1,3-diol or alfacacidol |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0981350B1 (en) |
JP (1) | JP2001511818A (en) |
KR (1) | KR20000075514A (en) |
CN (1) | CN1248168A (en) |
AT (1) | ATE206306T1 (en) |
AU (1) | AU6505098A (en) |
BR (1) | BR9807592A (en) |
CA (1) | CA2282086A1 (en) |
DE (1) | DE69801907D1 (en) |
FR (1) | FR2759586B1 (en) |
IL (1) | IL131502A0 (en) |
NO (1) | NO993997L (en) |
PL (1) | PL335190A1 (en) |
TR (1) | TR199901998T2 (en) |
WO (1) | WO1998036754A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004026811A (en) * | 2002-04-30 | 2004-01-29 | Kiyoshi Hashizume | Medicament for reinforcing anti-cancer activity, containing vitamin d3 derivative |
GB201704909D0 (en) * | 2017-03-28 | 2017-05-10 | Ldn Pharma Ltd | Cancer therapy |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57149224A (en) * | 1981-03-13 | 1982-09-14 | Chugai Pharmaceut Co Ltd | Tumor-suppressing agent |
IL110117A0 (en) * | 1994-06-24 | 1994-10-07 | Univ Ben Gurion | Pharmaceutical compositions comprising vitamin-d analogs |
-
1997
- 1997-02-20 FR FR9702247A patent/FR2759586B1/en not_active Expired - Fee Related
-
1998
- 1998-02-20 IL IL13150298A patent/IL131502A0/en unknown
- 1998-02-20 CN CN98802696A patent/CN1248168A/en active Pending
- 1998-02-20 AU AU65050/98A patent/AU6505098A/en not_active Abandoned
- 1998-02-20 JP JP53634498A patent/JP2001511818A/en active Pending
- 1998-02-20 TR TR1999/01998T patent/TR199901998T2/en unknown
- 1998-02-20 AT AT98910810T patent/ATE206306T1/en not_active IP Right Cessation
- 1998-02-20 DE DE69801907T patent/DE69801907D1/en not_active Expired - Lifetime
- 1998-02-20 BR BR9807592-6A patent/BR9807592A/en not_active Application Discontinuation
- 1998-02-20 PL PL98335190A patent/PL335190A1/en unknown
- 1998-02-20 EP EP98910810A patent/EP0981350B1/en not_active Expired - Lifetime
- 1998-02-20 WO PCT/FR1998/000347 patent/WO1998036754A1/en not_active Application Discontinuation
- 1998-02-20 KR KR1019997007573A patent/KR20000075514A/en not_active Application Discontinuation
- 1998-02-20 CA CA002282086A patent/CA2282086A1/en not_active Abandoned
-
1999
- 1999-08-19 NO NO993997A patent/NO993997L/en unknown
Also Published As
Publication number | Publication date |
---|---|
NO993997D0 (en) | 1999-08-19 |
FR2759586A1 (en) | 1998-08-21 |
ATE206306T1 (en) | 2001-10-15 |
TR199901998T2 (en) | 1999-11-22 |
EP0981350B1 (en) | 2001-10-04 |
PL335190A1 (en) | 2000-04-10 |
AU6505098A (en) | 1998-09-09 |
DE69801907D1 (en) | 2001-11-08 |
CA2282086A1 (en) | 1998-08-27 |
FR2759586B1 (en) | 2000-01-14 |
BR9807592A (en) | 2000-02-22 |
NO993997L (en) | 1999-10-19 |
CN1248168A (en) | 2000-03-22 |
KR20000075514A (en) | 2000-12-15 |
WO1998036754A1 (en) | 1998-08-27 |
JP2001511818A (en) | 2001-08-14 |
EP0981350A1 (en) | 2000-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP9801392A0 (en) | Concentrated antibody preparation. | |
HK1032759A1 (en) | Apparatus for restoring the balance of the human body. | |
HK1008180A1 (en) | Use of vitamin d 2 or vitamin d 4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism | |
EP0859637A4 (en) | Compositions for the treatment and diagnosis of body weight disorders, including obesity | |
CY2402B1 (en) | Metered dose inhaler for albuterol. | |
CS553490A3 (en) | Transdermal therapeutic system | |
WO1992012715A3 (en) | The use of loperamide and related compounds for treatment of respiratory disease symptoms | |
MX9602442A (en) | A single high dose fluroquinolone treatment. | |
AU5170499A (en) | Use of ginkgo biloba extracts for preparing a medicine for treating amyotrophic lateral sclerosis | |
HK1014498A1 (en) | Bpi-protein-products for depressed reticuloendothelial system function. | |
GB9808936D0 (en) | Combination therapy for the prevention and treatment of osteoporosis | |
HU904007D0 (en) | Medical preparations providing regulated active agent discharge and processes for the preparation thereof | |
BG102667A (en) | Diosgenine-containing composition | |
EP0744176A3 (en) | Methods for inhibiting bone loss | |
EP0592903A3 (en) | Use of ancrod for the preparation of drugs for the treatment of restenosis. | |
AU7105498A (en) | Combination therapy for the prevention and treatment of osteoporosis | |
IL131502A0 (en) | Use of 9,10-secocholesta-5,7,10 (19)-triene-1,3-diol or alfacacidol | |
PT81387A (en) | Process for preparing pharmaceutical compositions containing 1--beta-d-ribofuranosyl-1,2,4-triazole-3-carboxamide useful for treating human viral disfases | |
ZA924128B (en) | New combination preparations for treatment of Parkinson's disease. | |
HUP9802536A3 (en) | Pharmaceutical compositions containing 1,2,4-benzotriazine 1,4-dioxide and use thereof for the preparation of pharmaceutical compositions treating cancer | |
ZA944281B (en) | Use of efaroxan and its derivatives for the preparation of a medicinal product intented for the treatment of parkinson's disease | |
EP0624368A3 (en) | Use of a composition for stimulating the synthesis of glutathione in the manufacture of a medicament for the treatment of acquired immune deficiency syndrome. | |
AU6819898A (en) | Oxygen anion radicals and/or therapeutic preparations containing their reaction or breakdown products, and use of such preparations in the treatment of parkinson's disease | |
MY114109A (en) | The use of bioassimilable boron compounds | |
ZA9610264B (en) | Preparation for use in the treatment of skin disorders. |